{"id":25498,"date":"2016-04-13T18:17:42","date_gmt":"2016-04-13T16:17:42","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=25498"},"modified":"2016-04-13T18:24:55","modified_gmt":"2016-04-13T16:24:55","slug":"le-aziende-farmaceutiche-tornano-a-investire-nella-pubblicita-su-carta","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/le-aziende-farmaceutiche-tornano-a-investire-nella-pubblicita-su-carta\/","title":{"rendered":"Pharmaceutical companies are investing again in print advertising"},"content":{"rendered":"<h4 class=\"site-block__title\">In the United States, according to Kantar Media data, there was a turnaround with an increase in drug advertising spending of 8.4% in 2015<\/h4>\n<p><a href=\"http:\/\/www.aboutpharma.com\/blog\/2016\/04\/13\/le-aziende-farmaceutiche-tornano-a-investire-nella-pubblicita-su-carta\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">13 April 2016 \u2013 by Aboutpharma Online editorial staff<\/span><\/a><\/p>\n<p><img decoding=\"async\" class=\"alignleft\" src=\"http:\/\/www.aboutpharma.com\/wp-content\/uploads\/2016\/04\/node_pubblicazioni_scientifiche-e1460555223425-300x189.jpg\" alt=\"node_pubblicazioni_scientifiche\" \/>Good news for the world of scientific publishing. According to the latest Kantar Media data, in fact, there has been a turnaround and spending on drug advertising that companies reserve for paper newspapers has started to grow again.<\/p>\n<p>In 2015, advertising investments in the United States reached 372 million dollars, with a growth of 8.4 percent. The peak of sales was recorded in 2011 with 405 million dollars, while last year there was also an increase in the total number of pages dedicated to promotions in medical-surgical journals, which grew by 7.9 percent.<\/p>\n<p>New England Journal of Medicine, Journal of the American Medical Association, American Family Physician, Journal of Clinical Oncology and Medical Economics among the journals with the highest revenue from drug advertising. . On the corporate side, Johnson &amp; Johnson maintains its position as the \u201c2015 top spender\u201d in print promotion, despite a 13.5% decline in assets, to $30 million. Eli Lilly is placed s<img decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.kantarmedia.com\/assets\/images\/logo.png\" alt=\"\" \/>second with 22.5 million, Gilead third with 20 million.<\/p>\n<p>\u201cPeople still read print journals, which are very effective \u2013 says Art Wilschek, director of sales at the New England Journal of Medicine \u2013 digital is important, but it hasn&#039;t replaced them yet\u201d.<\/p>\n<p>Related news:\u00a0<a href=\"http:\/\/www.rifday.it\/2016\/04\/13\/le-relazioni-medici-farmacisti-pazienti-ai-tempi-del-dr-web-risultati-ricerca\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">The relationships between doctors, pharmacists and patients at the time of dr. Web, the results of a search<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Negli Stati Uniti, secondo i dati Kantar Media, c\u2019\u00e8 stata un\u2019inversione di tendenza con un incremento della spesa in pubblicit\u00e0 sui farmaci dell\u20198,4% nel 2015 13 aprile 2016 &#8211;\u00a0di Redazione Aboutpharma Online Buone notizie per il mondo dell\u2019editoria scientifica. Secondo gli ultimi dati\u00a0 Kantar Media infatti c\u2019\u00e8 stata un\u2019inversione di tendenza e la spesa in &hellip;<\/p>","protected":false},"author":4,"featured_media":25501,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[54],"class_list":["post-25498","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-marketing"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/25498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=25498"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/25498\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/25501"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=25498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=25498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=25498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}